Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06128395
Other study ID # 3384
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date October 30, 2024

Study information

Verified date November 2023
Source Clinique Ovo
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The use of low dose aspirin is recommended for high risk patients to reduce the risk of pre-eclampsia, placental abruption and antepartum hemorrhage. Recent studies have shown that in a specific population, the use of low dose aspirin might reduce the risk of preterm birth in pregnant women with singleton pregnancy. In June 2022, clinique ovo started implementing the use of Aspirin 162 mg instead of 81 mg in the frozen embryo transfer cycles based on recent study outcomes. The use of Aspirin 162 mg might have additional benefits on the embryo transfer outcomes by decreasing the miscarriage. Moreover this can be continued until late in pregnancy without adverse effects.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 500
Est. completion date October 30, 2024
Est. primary completion date August 30, 2024
Accepts healthy volunteers
Gender Female
Age group N/A to 40 Years
Eligibility Inclusion Criteria: - Women taking aspirin 81 mg or 162 mg prior to an autologous embryo transfer - Age < 40 years old - Embryo transfer cycle done at clinique ovo Exclusion Criteria: - Egg or embryo recipient - History of recurrent miscarriages, defined as = 3 consecutive losses - Patients that needed Viagra, PRP or other modalities to improve their endometrial thickness - Uterine factor infertility - Abnormal hormonal profiles - Stimulated embryo transfer cycles - History of recurrent implantation failure defined as failed = 2 euploid embryos transfer or = 3 blastocysts

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Frozen embryo transfer
A frozen embryo transfer involves thawing a fertilized embryo and transferring it in the uterus in order to obtain a pregnancy

Locations

Country Name City State
Canada Clinique Ovo Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Clinique Ovo

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare clinical pregnancy rate between patients prescribed Aspirin 81 mg vs Aspirin 162 mg clinical pregnancy is the presence of fetal heartbeat at the viability ultrasound Time Frame: 6 to 8 weeks after Frozen Embryo Transfer
See also
  Status Clinical Trial Phase
Recruiting NCT05634850 - Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
Completed NCT03803228 - Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders Phase 3
Active, not recruiting NCT06053827 - Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Recruiting NCT03480412 - Second Step Protocol in Poor Ovarian Responder (POR)
Not yet recruiting NCT04604054 - The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF N/A
Not yet recruiting NCT04606082 - Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI N/A
Not yet recruiting NCT04589793 - COaching Lifestyle Intervention for FErtility N/A
Completed NCT06441409 - Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease N/A
Completed NCT03846544 - Double Pick up in Poor Prognosis Women Phase 4
Completed NCT04141436 - Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF) N/A
Recruiting NCT05271981 - Fertility After Uterine Artery Embolization
Completed NCT03161873 - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed NCT03007043 - Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
Completed NCT04133402 - Fertility After Intrauterine Tamponing Balloon: Where Are we
Recruiting NCT05807256 - Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Completed NCT03908697 - Quantum Natural Family Planning Pilot N/A
Completed NCT04908774 - Effects of a Fasting Mimicking Diet on Sperm Quality N/A
Recruiting NCT05205733 - Expanding Fertility Care to Poor and Low Resourced Settings Study N/A
Active, not recruiting NCT03085212 - Strategies for Pregnancy Achievement N/A
Completed NCT01388907 - Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery Phase 4